Search Results - "DSOUZA, NINOSCHKA"
-
1
14-LB: Somatostatin Receptor 2 Antagonism Enhances Plasma Glucagon Levels during Insulin-Induced Hypoglycemia in a Rodent Model of Type 2 Diabetes Mellitus
Published in Diabetes (New York, N.Y.) (01-06-2019)“…Somatostatin Receptor 2 antagonists (SSTR2a) increase glucagon counter-regulation to hypoglycemia in various rodent models of type-1 diabetes mellitus. Here we…”
Get full text
Journal Article -
2
1778-LB: Comparing a Somatostatin Receptor 2 Antagonist (SSTR2a) to Exogenous Glucagon (EG) for the Treatment of Severe Insulin-Induced Hypoglycemia
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction & Objective: Treatment of severe hypoglycemia (SH) with EG causes hyperglucagonemia, resulting in gastrointestinal distress that limits its…”
Get full text
Journal Article -
3
1773-LB: Impact of SSTR2a Treatment in Hypoglycemia in Male (M) and Female (F) Rat Models of Type 2 Diabetes (T2D)
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction: A single dose of SSTR2a, ZT-01, reduces hypoglycemia exposure in diabetic rat models. However, the pharmacology of daily dosing in type 2…”
Get full text
Journal Article -
4
1774-LB: The Glucagon Stimulating Effect in Hypoglycemia of Somatostatin Receptor 2 Antagonist (SSTR2a) Is Maintained with Repeat Dosing
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction: A single dose of SSTR2a, ZT-01, reduces hypoglycemia exposure in diabetic rat models. However, the pharmacology of daily dosing in type 2…”
Get full text
Journal Article -
5
133-OR: Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats
Published in Diabetes (New York, N.Y.) (01-06-2021)“…Background: SSTR2a rescues glucagon counterregulation in type 1 diabetic rats. Here, we investigated its potential for resisting hypoglycemic onset in…”
Get full text
Journal Article -
6
9-LB: Increased Islet Expression of Somatostatin and Glucagon in Male Rats with Insulin-Dependent Type 2 Diabetes
Published in Diabetes (New York, N.Y.) (01-06-2022)“…Background: Pancreatic islet remodelling in type 1 diabetes increases somatostatin (SST) expression, which inhibits glucagon counterregulation to hypoglycemia…”
Get full text
Journal Article -
7
32-LB: Interstitial Glucose Levels during Exercise in Persons with and without Type 1 Diabetes
Published in Diabetes (New York, N.Y.) (01-06-2021)“…Background: Using continuous glucose monitoring (CGM), we investigated potential sex-related differences in glycemia during exercise in persons living with…”
Get full text
Journal Article